文献速递骨质疏松与钙磷/甲状旁腺

热消融治疗原发性甲状旁腺功能亢进的多中心疗效与安全性研究

Effectiveness and Safety of Thermal Ablation in the Treatment of Primary Hyperparathyroidism: A Multicenter Study.
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

该多中心回顾性研究纳入119例原发性甲状旁腺功能亢进患者(134个甲状旁腺结节),评估超声引导下热消融的疗效与安全性。技术成功率为98.3%,治愈率为89.9%,12个月消融灶体积缩小率为94.6%,并发症发生率为6.7%。研究表明热消融是治疗pHPT有效且安全的方法。

要点

  • 热消融治疗pHPT的技术成功率为98.3%,治愈率为89.9%。
  • 结节最大径≥0.6 cm者治愈率达95%,微波与射频消融6个月治愈率无差异。
  • 并发症发生率为6.7%,除1例持续性发声障碍外均在6个月内自行缓解。

核心结论

  • 热消融是治疗原发性甲状旁腺功能亢进有效且安全的方法。

研究设计与样本

  • 回顾性多中心研究,纳入2015年1月至2020年3月4个中心接受热消融治疗的119例pHPT患者(134个甲状旁腺结节),中位随访18.1个月(四分位距6.5-42.2个月)。

主要发现

  • 技术成功率为98.3%,治愈率为89.9%,治愈定义为整个随访期间(至少超过6个月)血清钙和全段甲状旁腺激素恢复正常。
  • 治愈患者与未消融靶病灶患者之间甲状旁腺最大径存在显著差异。
  • 除结节直径小于0.6 cm的病例外,治愈率为95%。
  • 消融灶12个月体积缩小率为94.6%,并发症发生率为6.7%(8/119),除1例持续性发声障碍外其余症状均在6个月内自行缓解。

关键数值与推荐

  • 治愈标准:整个随访期间(至少超过6个月)血清钙和全段甲状旁腺激素恢复正常。
  • 技术成功率为98.3%,治愈率为89.9%,结节直径≥0.6 cm者治愈率为95%。
  • 消融灶12个月体积缩小率为94.6%,并发症发生率为6.7%(8/119)。

临床怎么用

  • 对于原发性甲状旁腺功能亢进患者,尤其是结节最大径≥0.6 cm者,可考虑超声引导下热消融作为微创治疗选择。
  • 微波消融与射频消融在6个月治愈率上无显著差异,可根据临床条件选择。
  • 术后需监测并发症,多数症状可在6个月内自行缓解,但需警惕持续性发声障碍。

局限性

  • 回顾性研究设计可能存在选择偏倚。
  • 随访时间中位数为18.1个月,远期疗效有待进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Ultrasound (US)-guided thermal ablation has generated recent interest as minimally invasive treatments of primary hyperparathyroidism (pHPT). But definitive evidence for the efficacy of thermal ablation in treating pHPT is not well characterized. OBJECTIVE: This work aims to evaluate the effectiveness and safety of thermal ablation for pHPT. METHODS: From January 2015 to March 2020, data pertaining to patients who received thermal ablation for pHPT at 4 centers were retrospectively analyzed. The median follow-up duration was 18.1 months (interquartile range, 6.5-42.2 months). A cure referred to the reestablishment of normal values of serum calcium and intact parathyroid hormone throughout the entire follow-up period, at least more than 6 months. The technical success, effectiveness, and safety of treatment were analyzed. RESULTS: A total of 119 patients (mean age, 57.2 ± 16.3 years; 81 female) with 134 parathyroid nodules were enrolled. The mean maximum diameter of the parathyroid glands was 1.6 ± 0.9 cm. Ninety-six patients underwent microwave ablation (MWA), and 23 patients underwent radiofrequency ablation (RFA). The technical success rate was 98.3% and the cure rate was 89.9%. Significant differences were found in the maximum diameter between the cured patients and the patients who did not undergo ablation of the target lesions. Except for cases with pHPT nodules less than 0.6 cm in diameter, the cure rate was 95%. There were no difference in cure rates at 6 months between the MWA and RFA groups (MWA vs RFA, 90.6% vs 87.0%; χ 2 = 0.275, P = .699). The volume reduction rate of the ablation zone was 94.6% at 12 months. The complication rate was 6.7% (8/119). With the exception of one patient with persistent voice impairment, other symptoms spontaneously resolved within 6 months. CONCLUSION: Thermal ablation is effective and safe for pHPT.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Wei Y, Peng CZ, Wang SR, et al. Effectiveness and Safety of Thermal Ablation in the Treatment of Primary Hyperparathyroidism: A Multicenter Study. J Clin Endocrinol Metab. 2021. PMID: 33846740. doi:10.1210/clinem/dgab240

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。